Evidence map›Paper›PMID 42326688›Full record

ArticleACS omega2026

ATR-FTIR Assessment of the Antioxidant and Anti-Inflammatory Effects of (-)-Epicatechin in MASLD.

Marija Hefer, Nikolina Filipović, Stjepan Šarić, Nela Malatesti, Ana Petrović, Elvira Kovač-Andrić, Martina Smolić

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Marija HeferDepartment of Translational Medicine, Faculty of Dental Medicine and Health, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia.
Nikolina FilipovićDepartment of Chemistry, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia.
Stjepan ŠarićDepartment of Chemistry, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia.ORCID https://orcid.org/0000-0002-5276-4497
Nela MalatestiFaculty of Biotechnology and Drug Development, University of Rijeka, 51000 Rijeka, Croatia.ORCID https://orcid.org/0000-0001-6983-6576
Ana PetrovićDepartment of Translational Medicine, Faculty of Dental Medicine and Health, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia.
Elvira Kovač-AndrićDepartment of Chemistry, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia.
Martina SmolićDepartment of Translational Medicine, Faculty of Dental Medicine and Health, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia.ORCID https://orcid.org/0000-0002-6867-826X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lipid peroxidation is a contributor and a result of metabolic dysfunction-associated steatotic liver disease (MASLD), related to oxidative injury and inflammatory/fibrogenic signaling, which eventually results in disease progression. Early (conjugated dienes, CDs) and propagation (lipid hydroperoxides, LOOHs) products, along with attenuated total reflection-Fourier transform infrared (ATR-FTIR) spectroscopy assessment, could possibly be used to quantify the extent of this process, while TNF-α and TGF-β

Identifiers

PMID42326688
PMCPMC13280922

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.